Jafron Biomedical Co

Jafron Biomedical Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jafron Biomedical Co (300529.SZ) as of Oct 6, 2026 is 739.52 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 1.11 B CNY — a change of -33.49% (lower).

EBITDA

739.52 MCNY

YoY

-33.49%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jafron Biomedical Co is 2026 739.52 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jafron Biomedical Co was 2025 1.11 B CNY. It decreases by -33.49% lower compared to the previous year.

The Jafron Biomedical Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
486.31 M CNY
Jan 1, 2019
693.73 M CNY
Jan 1, 2020
1.07 B CNY
Jan 1, 2021
1.45 B CNY
Jan 1, 2022
1.07 B CNY
Jan 1, 2023
600.08 M CNY
Jan 1, 2024
1.11 B CNY
Jan 1, 2025
739.52 M CNY
The Jafron Biomedical Co EBITDA history
YEAREBITDAYoY
739.52 MCNY-33.49%
1.11 BCNY+85.29%
600.08 MCNY-43.91%
1.07 BCNY-26.14%
1.45 BCNY+35.20%
1.07 BCNY+54.46%
693.73 MCNY+42.65%
486.31 MCNY+43.79%
338.21 MCNY+41.53%
238.97 MCNY+1.11%
236.34 MCNY+34.33%
175.94 MCNY—
Access this data via the Eulerpool API
Get Free API Key

Jafron Biomedical Co Stock analysis

What does Jafron Biomedical Co do? Jafron Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Jafron Biomedical Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jafron Biomedical Co is 739.52 M CNY in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Jafron Biomedical Co changed from 1.11 B CNY to 739.52 M CNY, representing a -33.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Jafron Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Jafron Biomedical Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Jafron Biomedical Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Jafron Biomedical Co